Larson Financial Group’s Jade Biosciences JBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.45K Sell
103
-1
-1% -$20 ﹤0.01% 3316
2026
Q2
$2.31K Hold
104
– – ﹤0.01% 3065
2026
Q1
$1.46K Buy
104
+81
+352% +$1.17K ﹤0.01% 3057
2025
Q4
$355 Buy
+23
New +$270 ﹤0.01% 3186

Other funds holding JBIO

Larson Financial Group's JBIO Position: Q3 2026 in Review

Larson Financial Group reduced its Jade Biosciences (JBIO) stake by 0.96% in Q3 2026, selling an estimated $20 and leaving 103 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3316.

Larson Financial Group first reported a position in JBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.31K in Q2 2026. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.

  • Larson Financial Group held 103 shares of Jade Biosciences worth $1.45K as of Q3 2026.
  • Larson Financial Group sold 1 Jade Biosciences share in Q3 2026, an estimated $20.
  • Jade Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3316 holding.
  • Larson Financial Group first reported a position in Jade Biosciences in Q4 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Jade Biosciences position peaked at $2.31K in Q2 2026.
  • 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.